Jacobio Pharmaceuticals boosts treasury holdings with share repurchase

On September 25, 2025, Jacobio Pharmaceuticals Group Co., Ltd. repurchased 163,500 of its ordinary shares on the Exchange. The shares were bought at a volume-weighted average price of HK$9.171988, with the highest repurchase price at HK$9.57 and the lowest at HK$9.41. The aggregate price paid for these repurchased shares totaled HK$1,499,620.

These repurchased shares are being held as treasury shares, increasing the company's treasury share count from 3,182,700 to 3,346,200. Consequently, the number of issued shares (excluding treasury shares) decreased by 163,500, from 788,572,380 to 788,408,880. This repurchase represents 0.02073% of the existing number of issued shares before the event. The total number of issued shares remained at 791,755,080.

The repurchase was made under a mandate granted on June 10, 2025, which authorized the repurchase of up to 78,873,528 shares. To date, the company has repurchased 326,400 shares under this mandate, representing 0.04138% of the issued shares as of the resolution date. A moratorium period for new share issues or sales of treasury shares will be in effect until October 25, 2025.